Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

CSPC-NBP Pharmaceutical Co. Ltd.

www.nbp.com.cn/en

Latest From CSPC-NBP Pharmaceutical Co. Ltd.

Multinationals Look To M&A As Key China Growth Driver

Mergers and acquisitions have been highlighted as key drivers of growth for pharma companies in China as domestic companies look to expand globally and multinationals attempt to localize.

BioPharmaceutical Medical Device

Stroke Now Second Cause Of Death In China: Morgan Stanley Report

Total market share for drugs to treat stroke is roughly RMB 31 billion in China, with 2.5 million new cases in the country every year.

BioPharmaceutical China

After Tough 2011 For Chinese Healthcare IPOs, Policy And Cost Relief Could Be On The Way

China's pharma IPOs didn't meet the hype in 2011. Government action may now ease speculation mania.

BioPharmaceutical Medical Device
See All

Company Information

  • Industry
  • Medical Devices
  • Pharmaceuticals
  • Research, Analytical Equipment & Supplies
  • Therapeutic Areas
  • Neurology, Nervous System
  • Alias(es)
  • CSPC OYY
  • CSPC XNW
  • ShiJiaZhuang Pharmaceutical Group Corp.
  • China ShiJiaZhuang Pharmaceutical Group Corp.
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • Asia
      • China
  • Parent & Subsidiaries
  • CSPC-NBP Pharmaceutical Co. Ltd.
  • Senior Management
  • Contact Info
  • CSPC-NBP Pharmaceutical Co. Ltd.
    Phone: (86) 311-83092888
    Liangcun High-Tech Zone, Shijiazhuang
    Shanxi Sheng, 052160
    China
UsernamePublicRestriction

Register